EBV and hemophagocytic syndrome: Analysis of 3 cases, with speculation on clinical features, therapy and role of EBV

Journal of the Medical Association of Thailand

Volumn 87, Issue 8, 2004, Pages 974-983

  Srichaikul, Tanomsri ^a   Punyagupta, Sompone ^a   Mongkolsritrakul, Wichian ^b   Jidpugdeebodin, Suwanee ^a  

^a Vichaiyut Hospital   (Thailand)

^b THAMMASAT UNIVERSITY   (Thailand)

Author keywords

Early diagnosis and treatment; Epstein Barr virus; Hemophagocytic syndrome; Malignant lymphoma

Indexed keywords

ALEMTUZUMAB; AMPHOTERICIN B; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; CISPLATIN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS RNA ENCODED ANTIGEN; ETOPOSIDE; GANCICLOVIR; IMMUNOGLOBULIN; MEROPENEM; METHYLPREDNISOLONE; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS DNA;

ANTIBIOTIC THERAPY; ARTICLE; B CELL LYMPHOMA; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG PULSE THERAPY; EARLY DIAGNOSIS; EPSTEIN BARR VIRUS; FEVER; HEMOPHAGOCYTIC SYNDROME; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; IN SITU HYBRIDIZATION; LABORATORY TEST; LIVER DYSFUNCTION; PANCYTOPENIA; PLASMAPHERESIS; PROGNOSIS; SPLENOMEGALY; T CELL LYMPHOMA; THAILAND; VIRUS INFECTION; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; BONE MARROW; CYCLOPHOSPHAMIDE; EPSTEIN-BARR VIRUS INFECTIONS; FATAL OUTCOME; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER FUNCTION TESTS; LYMPHOMA, T-CELL; MALE;

EID: 4544283045     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Swaminathan S. Molecular Biology of Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus. Seminars in Hematology 2003; 40: 107-15.
2. Epstein M, Achong B, Barr YM. Virus particles in cultured lympoblasts from Burkitt's lymphoma. Lancet 1964; 1: 702-70.
3. Pathmanathan R, Presad U, Sander R, Flynn K, Raab-Traub N. Clonal proliferation of cells infected with EBV in preinvasive lesions related to nasopharyneal carcinoma. N Engl J Med 1995; 333: 693-8.
4. Imai S, Koizumi S, Sugiura M, Tokunaga M, Uemura Y, Yamamoto N, et al. Gastric carcinoma: monoclonal epithelial malignant cells expressing EBV latent infection protein. Proceeding of the National Academy of Sciences of the USA 1994; 91: 9131-5.
5. Yachie A, Kanegane H, Kasahara Y. Epstein-Barr Virus-Associated T-/Natural Killer Cell Lymphoproliferative Diseases. Seminars in Hematology 2003; 40: 124-32.
6. Mitarnun W, Saechan V, Pradutkanchana J, Wuwiwat S, Takao S, Ishida T. J Med Assoc Thai 2003; 86: 816-28.
7. Mitarnun W, Suwiwat S, Pradutkanchana J, Saechan V, Ishida T, Takao S, Mori A. EBV associated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic and molecular analysis. Amer J Hematology 2002; 70: 31-8.
8. Cohen IJ. Benign and Malignant Epstein-Barr Virus-Associated B-Cell Lymphoprolifeative Diseases. Seminars in Hematology 2003; 40: 116-23.
9. Anwar N, Kingma DW, Bloch AR, Mourad M, Raffeld M, Franklin J, Magrath I, Bolkainy N, Jaffe ES. The insertigation of EBV sequences in 41 cases of Burkitt's lymphoma from Egypt epidemiologic correlations. Cancer 1995; 176: 1245-52.
10. Thomas JA, Crawford DH, Burke M. Clinicopathologic implication of EBV related B cell lymphoma in immunocompromised patients. J Clin Pathol 1999; 48: 270-87.
11. Risdall RJ, McKenna RW, Nesbit ME, Krivit W, Balfour HH Jr, Simmons RL, Brunning RD. Virus-associated hemophagocytic syndrome: A benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 1979; 44: 993-1002.
12. Veerakul G, Sanpakit K, Tanphaichitr V, Mahasandona C, Jiraratanasopa N. Secondary hemophagocytic lymphohistiocytosis in children: an analysis of etiology and outcome. J Med Assoc Thailand 2002; 85: S531-40.
13. Wong K.F, Chan J.K.C, Lo E.S.F, Wong C.S.C. A study of the possible etiologic association of Esptein-Barr Virus with reactive hemophagocytic syndrome in Hong Kong Chinese. Human Pathology 1996; 27: 1239-42.
14. Kikuta H, Sakiyama Y, Matsumoto S, Oh-Ishi T, Nakano T, Nagashima T, Oka T, Hironaka T, Hirai K. Fatal Epstein-Barr Virus-associated hemophagocytic syndrome. Blood 1993; 82: 3259-64.
15. Reiner A, Spivak J. Hematophagic histiocytosis. Medicine 1988; 67: 369-88.
16. Sullivan JL, Woda BA, Herrod HG, Koh G, Rivara FP, Mulder C. Reactive hemophagocytic syndrome; virological and immunopathological studies. Blood 1985; 65: 1097-104.
17. Mihara H, Kato Y, Tokura Y, Hattori Y, Sato A, Kobayashi H, Imamura A, Daimaru O, Miwa H, Nitta M. Esptein-Barr virus - associated hemophagocytic syndrome during mid-term pregnancy successfully treated with combined methylpredisolone and intravenous immunoglobulin. Rinsho Ketsueki 1999; 40: 1258-64.
18. Emmenegger U, Frey U, Reimers A, Fux C, Semela D, Cottagnoud P, Spaeth PJ, Neftel KA. Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes. Am J Hematol 2001; 68: 4-10.
19. Imashuku S, Hibi S, Ohara T, Iwai A, Sako M, Kato M, Arakawa H, Sotomatsu M, Kataoka S, Asami K, Hasegawa D, Kosaka Y, Sano K, Igarashi N, Maruhashi K, Ichimi R, Kawasaki H, Maeda N, Tanizawa A, Arai K, Abe T, Hisakawa H, Miyashita H, Henter JI. Effective control of esptein-Barr virus-related hemophagocyitc lymphohistiocytosis with immunochemotherapy. Blood 1999; 93: 1869-74.
20. Gomyo H, Shimoyama M, Minagawa K, Yakushijin K, Urahama N, Okamura A, et al. Effective anti-viral therapy for HPCS associated with B-cell lymphoma. Leuk Lymphoma 2003; 44: 1807-10.
21. Talag AH, Mohamed AE, Dafulla MM. Hemophagocytic syndrome. Saudi Med. J. 2000; 21: 979-82.
22. Kikuta H, Sakiyama Y, Marsumoto S, Oh-Ishi T, Nakano T, Nagashima T, Oka T, Hironaka T, Hirai K. Fatal Epstein-Barr Virus-Associated Hemophagocytic Syndrome. Blood 1993; 82: 3259-64.
23. Su IJ, Chen RL, Lin DT, Lin KS, Chen CC. Epstein-Barr Virus (EBV) Infects T Lymphocytes in Childhood EBV-Associated Hemophagocytic Syndrome in Taiwan. Amer J Patho 1994; 144: 1219-25.
24. Eakle JF, Bressound PF. Hemophagocytic syndrome following an Epstein-Barr virus infection: a case report and literature review. J Ky Med Assoc 2000; 98(4): 161-5.
25. Okano M & Gross TG. Epstein-Barr virus-associated hemophagocytic syndrome and fatal infectious mononucleosis. American Journal of Hematology 1996; 53: 111-5.
26. Su IJ, Wang CH, Cheng AC & Chen RL. Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis and mangement. Leukemia and Lymphoma 1995; 19: 401-6.
27. Akashi K Hayashi S Gondo H, et al. Involvement of interferon-gamma and macrophage colony-stimulating factor in pathogenesis of hemophagocytic lymphohistiocytosis in adults. British Journal of Hoematology 1994; 87: 243-51.
28. Mountford AP, Coulson PS, Cheever AW, Sher A, Wilson RA, Wynn TA. Interleukin-12 can directly induce T-helper I responses in interferon-gamma (IFN-gamma) receptor-deficient mice, but requires IFN-gamma signaling to downregulate T-helper 2 responses. Immunology 1995; 97: 588-94.
29. Fisman DN. Hemophagocytic syndrome and infection. Emerg Infect Dis 2000; 6: 601-8.
30. Lay J, Tsao C, Chen J, Kadin M, Su I. Upregulation of tumor necrosis factor-α gene by Esptein-Barr Virus and activation of macrophages in Epstein-Barr Virus-infected T cells in the pathogenesis of hemophagocytic syndrome. Clin Invest 1997; 10: 1969-79.
31. Lay JD, Chuang SE, Rowe M, Su IJ. EBV latent membrane protein I mediates upregulation of TNF α in EBV-infected T cells: implication for the pathogenesis of HPCS. J. Biomed. Sci 2003; 10: 146-55.
32. Ohshima K, Shimazaki K, Sugihara M, Haraoka S, Suzumiya J, Kanda M, Kawasaki C, Kiduchi M. Clincopathological findings of virus-associated hemophagocytic syndrome in bone marrow: association with Epstein-Barr virus and apoptosis. Pathol Int. 1999; 49: 533-40.
33. Harabuchi Y, Yamanaka N, Kataura A, Imai S, Kinoshita T, Mizuno F, et al. Epstein-Barr virus in nasal T-cell lymphoma in patients with lechal midline granuloma. Lancet 1990; 335: 128-30.
34. Su IJ, Hsieh HC, Lin KH, Uen WC, Kao CL, Chen CJ, et al. Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathological and molecular genetic study. Blood 1991; 77: 799-808.
35. Kawa-Ha K, Ishihara S, Ninomiya T, Yamura-Yagi K, Hara J, Murayama F, et al. CD3 negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. Journal of Clinical Investigation 1989; 84: 51-4.
36. d'Amore F, Johansen P, Houmand A, Weisenburger DD, Mortensen LS. Epstein-Barr virus Genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Blood 1996; 87: 1045-55.
37. Su IJ, Chen RL, Lin DT, Lin KS, Chen CC. Epstein-Barr Virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan. Am J Path. 1994; 144: 1219-25.
38. Takahashi N, Chubachi A, Miura I, Nakamura S, Miura AB. Lymphoma associated hemophagocytic syndrome in Japan. Rinsho Ketsueki 1999; 40: 542-9.
39. Onishi Y, Hotta S, Iwamoto H, Kamoshida T, Takahashi A, Imai Y. An autopsy case of intravascular malignant lymphomatosis with hemophagocytic syndrome, mental confusion and liver dysfunction. Rinsho Ketsueki 1998; 39(8): 586-92.
40. Miyahara M, Sano M, Shibata K, Matsuzaki M, Ibaraki K, Shimamoto Y, Tokunaga O. B-cell lymphoma-associated hemophagocytic syndrome: clinicopathological characteristics. Ann Hematol 2000; 79: 378-88.
41. Shimazaki C, Inaba T, Shimura K, Okamoto A, Takahashi R, Hirai H, Sudo Y, Ashihara E, Adachi Y, Murakami S, Saigo K Fujita N, Nakagawa M. B-cell lymphoma associated with haemophagocytic syndrome: a clinical, immunological and cytogenetic study. Br J Haemato 1999; 104(4): 672-9.
42. Ohno T, Miyake N, Hada S, Hirose Y, Imura A, Hori T, et al. Hemophagocytic syndrome in five patients with EBV negative B cell lymphoma. Cancer 1998; 82: 1963-72.
43. Kobbervig C, Norback D, Kahl B. Infectious mononucleosis progressing to fatal malignant lymphoma: a case report and review of the literatures. Leuk. Lymphoma 2003; 44: 1215-21.
44. Srichaikul S, Sonakul D, Preecha M, et al. Pleomorphic large cell hemato-Lymphoma (The so called "malignant histiocytosis"): clinicopathological and immunophenotypic studies in 35 cases. J Med Ass Thai 1994; 77: 588-98.